Elanco Animal Health Incorporated Stock Falls 1.90% Despite Prime Time To Acquire
June 19, 2023
🌥️Trending News
Elanco Animal Health ($NYSE:ELAN) Incorporated, a global leader in animal health, experienced a 1.90% decline in its stock price today, closing at $8.24, down from its previous closing price of $8.40. This may leave many investors wondering if this is the optimal time to invest in the company. Elanco Animal Health Incorporated is dedicated to helping provide solutions for animal health and nutrition. They are a trusted partner for veterinarians, farmers, pet owners, and others in the animal health industry. In addition to developing innovative products, the company is deeply committed to animal welfare and sustainability. Their current portfolio includes products such as antibiotics, vaccines, parasite protection, and nutrition solutions.
Elanco Animal Health Incorporated is constantly striving to develop new solutions to meet the changing needs of the industry. With their portfolio of products and services, they are positioned to capitalize on the growing demand for animal health solutions worldwide. With the stock falling 1.90% today, it could be a great opportunity for investors to get in on the ground floor of this dynamic company. With their commitment to innovation and powerful portfolio of products, Elanco Animal Health Incorporated could be a great long-term investment for any investor.
Analysis
We at GoodWhale have analyzed ELANCO ANIMAL HEALTH’s financials and come to the conclusion that it is a high risk investment. Our Risk Rating technology has detected 3 risk warnings in income sheet, balance sheet and cashflow statement. If you are considering investing in this company, we advise that you register with us to check out these warnings. Our experts can also provide you with more detailed insights into the financials of the company, so that you can make an informed decision. More…
About the Company
Income Snapshot
Below shows the total revenue, net income and net margin for ELAN. More…
| Total Revenues | Net Income | Net Margin |
| 4.44k | -23 | 2.1% |
Cash Flow Snapshot
Below shows the cash from operations, investing and financing for ELAN. More…
| Operations | Investing | Financing |
| 452 | -179 | -549 |
Balance Sheet Snapshot
Below shows the total assets, liabilities and book value per share for ELAN. More…
| Total Assets | Total Liabilities | Book Value Per Share |
| 15.49k | 8.2k | 14.81 |
Key Ratios Snapshot
Some of the financial key ratios for ELAN are shown below. More…
| 3Y Rev Growth | 3Y Operating Profit Growth | Operating Margin |
| 14.0% | 12.3% | 4.9% |
| FCF Margin | ROE | ROA |
| 6.0% | 1.9% | 0.9% |
Peers
The company’s competitors include GeneFerm Biotechnology Co Ltd, Rhone Ma Holdings Bhd, and Phibro Animal Health Corp.
– GeneFerm Biotechnology Co Ltd ($TPEX:1796)
Ferm Biotechnology Co Ltd is a company that manufactures and sells biotechnology products. The company has a market cap of 2.34B as of 2022 and a return on equity of 9.05%. The company’s products are used in the healthcare, food and beverage, and industrial markets.
– Rhone Ma Holdings Bhd ($KLSE:5278)
Rhone Ma Holdings Bhd is a Malaysia-based investment holding company. The Company, through its subsidiaries, is engaged in the provision of management services, banking and financial services, and investment holding. The Company’s segments include Commercial Banking, which is engaged in the provision of banking products and services to small and medium enterprises (SMEs) and individuals; Treasury, which is engaged in the provision of foreign exchange and money market services; and Corporate Banking, which is engaged in the provision of financing solutions to SMEs and large corporations.
– Phibro Animal Health Corp ($NASDAQ:PAHC)
Phibro Animal Health Corp is a publicly traded company that focuses on animal health and nutrition. As of 2022, the company had a market capitalization of 505.49 million and a return on equity of 19.25%. Phibro Animal Health Corp was founded in 1947 and is headquartered in Teaneck, New Jersey. The company’s products include pharmaceuticals, vaccines, and nutritional supplements for livestock, poultry, and aquaculture.
Summary
Elanco Animal Health Incorporated is currently trading at $8.24, which is a 1.90% decrease from its previous closing price of $8.40. Investors should assess the current market conditions and analyze the company’s financial performance before investing in Elanco Animal Health Incorporated stock. It is important to consider any potential risks, such as the company’s debt level, cash flow, profitability, and industry trends. Furthermore, investors should keep an eye on the company’s competitive landscape, management team, and future product developments to determine if Elanco Animal Health Incorporated is a worthwhile investment.
Investing Everyone Can Do.
Investing shouldn’t be exclusive to a select few. We believe everyone should have the opportunity to grow their wealth. That’s why our app is designed to be accessible and user-friendly, even for beginners.
